Clearance of 25-hydroxyvitamin D in Cystic Fibrosis (CF)

NCT03104855 PHASE1 COMPLETED Results posted

The goal of this study is to define 25(OH)D3 catabolism in CF patients using gold standard pharmacokinetics studies. Specifically, the investigators will evaluate the metabolic clearance of 25(OH)D3 among participants with CF and matched control subjects. The goal of this work is to provide the first comprehensive characterization of vitamin D metabolism in CF patients and promote novel hypotheses for subsequent studies.

Details

Lead sponsor	University of Washington
Phase	PHASE1
Status	COMPLETED
Enrolment	10
Start date	Mon Apr 03 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Wed Sep 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

• Cystic Fibrosis

Interventions

• d6-25-hydroxyvitamin D3

Countries

United States